The future of wellness doesn’t involve needles
Fill out a quick online intake form. No waiting rooms, no awkward convos.
A licensed PlutoCare physician reviews your health history and recommends a treatment.
Same-day review. No costly doctor-guided plans or consultations required.
Approved prescriptions ship within 48–72 hours. No needles, no fuss.
Place under your tongue each morning — and go about your day.
Our formulations use the same active ingredients as branded GLP-1 agonists but are compounded for oral/sublingual use. Compounded medications are not FDA-approved; efficacy and tolerability can differ from injectables. Your licensed provider will determine appropriateness.
Semaglutide/Tirzepatide: Regulate appetite, slow gastric emptying, and improve insulin sensitivity.
The active molecules in our semaglutide and tirzepatide compounds are the same as FDA-approved brands. We source generics from FDA-inspected, 503 A&B-compliant facilities.
Individual results vary based on prescribed drug type, adherence, and metabolism.
Most patients lose 10 – 25% of body weight over 12–16 weeks when following your personalized diet and exercise guidelines.
Common effects include nausea, vomiting, diarrhea, constipation. Not for patients with personal/ family history of medullary thyroid carcinoma or MEN2.
No. However, to optimize and accelerate outcomes, providers recommend a balanced, moderate-calorie diet and 150+ minutes of moderate exercise per week.
